Soothe Versus Refresh

NCT00284999 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 33

Last updated 2006-08-22

No results posted yet for this study

Summary

To determine the ocular efficacy and safety of Soothe and Refresh Tears.

Conditions

  • Dry Eye Syndromes

Interventions

DRUG

Soothe

DRUG

Refresh Tears

Sponsors & Collaborators

  • Pharmaceutical Research Network

    lead OTHER

Principal Investigators

  • William C. Stewart, MD · Pharmaceutical Research Network, LLC

  • Penny Asbell, MD · Icahn School of Medicine at Mount Sinai

  • Christopher Chow, MD · Michigan Cornea Associates

  • Douglas G. Day, MD · Coastal Research Associates, LLC

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Completion
2006-08-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00284999 on ClinicalTrials.gov